Work

A phase I study of [225Ac]Ac-PSMA-XT, a novel alpha-particle–emitting radioligand therapy, in patients with metastatic castration-resistant prostate cancer.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.5063

Authors: Xiaorong Sun, Fenghao Sun, Shouzhen Chen, Mingshan Yang, Minghuan Li, Ni Xu, Ligang Xing

Institutions: Shandong Tumor Hospital, Shandong First Medical University, Shandong University, Qilu Hospital of Shandong University

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162521114

Cites:

Cited by:

Related to: